{"mainPropery":{"diseaseId":4919,"diseaseName":"Spastic paraplegia 11","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/4919/spastic-paraplegia-11","synonyms":["SPG11","Hereditary spastic paraplegia mental impairment and thin corpus callosum","Autosomal recessive spastic paraplegia type 11","Hereditary spastic paraplegia 11","Nakamura Osame syndrome","Spastic paraplegia - intellectual deficit - thin corpus callosum"],"synonyms-with-source":[{"name":"SPG11"},{"name":"Hereditary spastic paraplegia mental impairment and thin corpus callosum"},{"name":"Autosomal recessive spastic paraplegia type 11"},{"name":"Hereditary spastic paraplegia 11"},{"name":"Nakamura Osame syndrome"},{"name":"Spastic paraplegia - intellectual deficit - thin corpus callosum"}],"identifiers":[{"identifierType":"OMIM","identifierId":"604360"},{"identifierType":"ORPHANET","identifierId":"2822"},{"identifierType":"UMLS","identifierId":"C1858479"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":61,"resourceName":"Spastic Paraplegia Foundation","abbreviation":"SPF","address1":"1605 Goularte Place","address2":"","address3":"","address4":"","address5":"","city":"Fremont","state":"CA","zip":"94539-7241","country":"United States","phone":"1-877-773-4483 ","tty":"","tollFree":"","fax":"1-877-773-4483 ","email":"information@sp-foundation.org","url":"https://sp-foundation.org/","freeText":""},{"resourceID":403,"resourceName":"Ataxia UK","abbreviation":"","address1":"12 Broadbent Close ","address2":"","address3":"","address4":"","address5":"","city":"London","state":"","zip":" N6 5JW","country":"United Kingdom","phone":"020 7582 1444 ","tty":"","tollFree":"0845 644 0606 (Helpline)","fax":"","email":"helpline@ataxia.org.uk","url":"https://www.ataxia.org.uk/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/604360' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=spastic%5BTitle/Abstract%5D%20AND%20paraplegia%5BTitle/Abstract%5D%20AND%2011%5BTitle/Abstract%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Spastic paraplegia 11. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://www.ghr.nlm.nih.gov/condition=spasticparaplegiatype11' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Spastic paraplegia 11. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":346,"resourceId":1163,"resourceName":"RareConnect- Hereditary Spastic Paraplegia","descriptionText":"<a href='http://www.rareconnect.org/en/community/hereditary-spastic-paraplegia ' target='_blank'>RareConnect</a> is an online social network for patients and families to connect with one another and share their experience living with a rare disease. The project is a joint collaboration between EURORDIS (European Rare Disease Organisation) and NORD (National Organization for Rare Disorders). Click on the link above to view the community for Hereditary spastic paraplegia.","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":858,"resourceId":1568,"resourceName":"Spastic paraplegia 11","descriptionText":"The <a href='http://www.merck.com/mmhe/sec06/ch093/ch093f.html?&amp;alt ' target='_blank'>Merck Manuals Online Medical Library</a> provides information on hereditary spastic paraplegia in general. To view the information page click on the link above.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":859,"resourceId":1568,"resourceName":"Spastic paraplegia 11","descriptionText":"The <a href='https://www.ninds.nih.gov/disorders/all-disorders/hereditary-spastic-paraplegia-information-page' target='_blank'>National Institute of Neurological Disorders and Stroke</a> offers information on hereditary spastic paraplegia. Click on the link above to view the information page.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":860,"resourceId":1568,"resourceName":"Spastic paraplegia 11","descriptionText":"The <a href='http://www.med.umich.edu/hsp/ ' target='_blank'>Univeristy of Michigan</a>'s Fink Laboratory Web site offers further information on hereditary spastic paraplegia. Click on the link above to view the information page.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":861,"resourceId":1568,"resourceName":"Spastic paraplegia 11","descriptionText":"The <a href='http://neuromuscular.wustl.edu/spinal/fsp.html#spgmu ' target='_blank'>Washington University, St. Louis </a>Neuromuscular Disease Center provides an outline on spastic paraplegia 11. Click on the link above to view the information page. ","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2822' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=spg11' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:604360' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":3331,"questionText":"What is spastic paraplegia 11?","answerText":"<strong>Spastic paraplegia&nbsp;11 (SPG11)</strong> is a form of <a href=\"https://rarediseases.info.nih.gov/GARD/Condition/6637/Hereditary_spastic_paraplegia.aspx\" target=\"_blank\">hereditary spastic paraplegia</a>. People with SPG11 experience worsening muscle stiffness leading to eventual paralysis of the lower limbs, as well as a range of other neurologic symptoms that may include intellectual disability, speech difficulties (dysarthria), and reduced bladder control.[2296] Additionally, the tissue connecting the left and right halves of the brain (corpus callosum) is abnormally thin in most individuals with SPG11. Onset of symptoms typically occurs during infancy or adolescence.[2298][11610] SPG11 is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in the <em><a href=\"http://www.ghr.nlm.nih.gov/gene=spg11\" target=\"_blank\">SPG11</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> fashion.[2297] Treatment is focused on managing symptoms and may include physical therapy and antispastic medications to prolong muscle control.[2298]<br />\r\n<br />","dateModified":"2016-05-31T00:00:00"},"basicQuestions":[{"questionId":3332,"questionText":"What are the signs and symptoms of spastic paraplegia 11 (SPG11)?\r\n<p>&nbsp;</p>","answerText":"Signs and symptoms of SPG11 may include:[2297][2298]<br />\r\n<ul>\r\n    <li>&nbsp;<a href=\"http://www.ninds.nih.gov/disorders/spasticity/spasticity.htm\" target=\"_blank\">Spasticity</a> (progressive muscle stiffness)</li>\r\n    <li>&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/paralysis.html\" target=\"_blank\">Paraplegia</a>(eventual&nbsp;paralysis of the lower limbs) &nbsp;</li>\r\n    <li>&nbsp;Numbness, tingling, or pain in the arms and legs&nbsp;</li>\r\n    <li>&nbsp;Disturbance in the nerves used for muscle movement&nbsp;</li>\r\n    <li>&nbsp;<a href=\"http://www.parentcenterhub.org/repository/intellectual/#def\" target=\"_blank\">Intellectual disability</a></li>\r\n    <li>&nbsp;Exaggerated reflexes of the lower limbs&nbsp;</li>\r\n    <li>&nbsp;Speech difficulties (dysarthria)</li>\r\n    <li>&nbsp;Reduced bladder control&nbsp;</li>\r\n    <li>&nbsp;Muscle wasting&nbsp;</li>\r\n</ul>\r\n<p>Less common features, include:[2297]</p>\r\n<ul>\r\n    <li>Difficulty swallowing (dysphagia)</li>\r\n    <li>High-arched feet&nbsp;</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/scoliosis.html\" target=\"_blank\">Scoliosis</a>&nbsp;</li>\r\n    <li><a href=\"http://www.aoa.org/x9763.xml\" target=\"_blank\">Involuntary movements of the eyes</a></li>\r\n</ul>\r\n<p>Age&nbsp;at time of&nbsp;symptom onset&nbsp;varies from&nbsp;infancy&nbsp;to early adulthood, with onset in infancy to adolescence being most common. Learning disability may begin in childhood. Most people experience a decline in intellectual ability and an increase in muscle weakness and nerve abnormalities over time. As the condition progresses, some people require wheelchair assistance (often 10 to 20 years after&nbsp;symptom onset).[2297][2298]</p>","dateModified":"2016-05-31T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":2297,"authors":"","articleTitle":"Spastic paraplegia type 11","bookWebsiteJournalTitle":"Genetics Home Reference","date":"2009","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/spastic-paraplegia-type-11","dateAccessed":"2016-05-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2298,"authors":"Stevanin G, Durr A, Brice A","articleTitle":"Spastic paraplegia 11","bookWebsiteJournalTitle":"GeneReviews","date":"January 31, 2013","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1210/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10716,"questionText":"How is spastic paraplegia 11 (SPG11) inherited?","answerText":"SPG11 is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>&nbsp;manner.[2298] This means that to be affected, a person must have a&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutation</a>&nbsp;in both copies of the responsible&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">gene</a>&nbsp;in each cell. Affected people inherit one mutated copy of the gene from each parent, who is referred to as a&nbsp;<a href=\"http://www.genome.gov/glossary/?id=23\" target=\"_blank\">carrier</a>. Carriers of an autosomal recessive condition typically do not have any signs or symptoms (they are unaffected). When 2 carriers of an autosomal recessive condition have children, each child has a:\r\n<ul>\r\n    <li>25% (1 in 4) chance to be affected</li>\r\n    <li>50% (1 in 2) chance to be an unaffected carrier like each parent</li>\r\n    <li>25% chance to be unaffected&nbsp;<em>and</em>&nbsp;not be a carrier</li>\r\n</ul>\r\n<strong></strong>","dateModified":"2016-05-31T10:07:00","resourceClassificationName":"Inheritance","references":[{"referenceId":2298,"authors":"Stevanin G, Durr A, Brice A","articleTitle":"Spastic paraplegia 11","bookWebsiteJournalTitle":"GeneReviews","date":"January 31, 2013","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1210/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10717,"questionText":"How might spastic paraplegia 11 (SPG11) be treated?","answerText":"Care for SPG11 is usually managed by a team including a&nbsp;<a href=\"http://kidshealth.org/en/parents/primary-care-physician.html\" target=\"_blank\">primary care physician</a>,&nbsp;<a href=\"https://patients.aan.com/go/workingwithyourdoctor\" target=\"_blank\">neurologist</a>, genetics professional (<a href=\"http://www.ashg.org/education/careers.shtml\" target=\"_blank\">geneticist</a>&nbsp;and/or&nbsp;<a href=\"https://www.nlm.nih.gov/medlineplus/geneticcounseling.html\" target=\"_blank\">genetic counselor</a>),<a href=\"http://kidshealth.org/en/kids/physical-therapy.html\" target=\"_blank\">&nbsp;physical therapist</a>,&nbsp;<a href=\"https://www.socialworkers.org/pressroom/features/general/profession.asp\" target=\"_blank\">social worker</a>, and&nbsp;<a href=\"http://www.apa.org/helpcenter/about-psychologists.aspx\" target=\"_blank\">psychologist</a>. Treatment is focused on alleviating symptoms and may include:<br />\r\n<ul style=\"list-style-type: disc;\">\r\n    <li>Medications for leg spasticity (antispastic drugs)</li>\r\n    <li>Medications to assist in bladder control (anticholinergic antispasmodic drugs)&nbsp;</li>\r\n    <li>Regular physician therapy</li>\r\n    <li><a href=\"https://www.nlm.nih.gov/medlineplus/botox.html\" target=\"_blank\">Botulinum toxin</a>&nbsp;and&nbsp;<a href=\"http://www.mayoclinic.org/drugs-supplements/baclofen-intrathecal-route/description/drg-20062155\" target=\"_blank\">intrathecal baclofen</a>&nbsp;for severe spasticity&nbsp;</li>\r\n</ul>\r\nRegular outpatient clinic evaluations are recommended to adjust medications and physical therapy/rehabilitation routines. Routine brain <a href=\"https://www.nlm.nih.gov/medlineplus/mriscans.html\" target=\"_blank\">MRI</a>&nbsp; and electrophysiological investigations (muscle and nerve studies) may be useful to follow the progression of the disease.[2298]","dateModified":"2016-05-31T10:25:00","resourceClassificationName":"Treatment","references":[{"referenceId":2298,"authors":"Stevanin G, Durr A, Brice A","articleTitle":"Spastic paraplegia 11","bookWebsiteJournalTitle":"GeneReviews","date":"January 31, 2013","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1210/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10718,"questionText":"What is the long-term outlook for spastic paraplegia 11 (SPG11)?","answerText":"The severity of symptoms in SPG11 worsen over time, with most individuals experiencing full clinical symptoms 10 years after onset. Most individuals with SPG11 require wheelchair assistance 10-20 years after onset. Intellectual disability and cognitive decline additionally typically worsen over time and may include short-term memory impairment, constant fluctuations in emotions, reduced verbal abilities, and attention deficits.[2298]","dateModified":"2016-05-31T11:21:00","resourceClassificationName":"Prognosis","references":[{"referenceId":2298,"authors":"Stevanin G, Durr A, Brice A","articleTitle":"Spastic paraplegia 11","bookWebsiteJournalTitle":"GeneReviews","date":"January 31, 2013","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1210/","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12747,"relatedDiseaseName":"Hereditary spastic paraplegia - autosomal dominant inheritance","relation":"Parent","isRare":true,"hasGardPage":false},{"relatedDiseaseId":12748,"relatedDiseaseName":"Hereditary spastic paraplegia - autosomal recessive inheritance","relation":"Parent","isRare":true,"hasGardPage":false}],"gardCases":[{"caseId":26073,"abbreviatedInquiry":"What is this exactly and how does it effect someone?","caseQuestions":[{"questionId":3331,"questionText":"What is spastic paraplegia 11?","answerText":"<strong>Spastic paraplegia&nbsp;11 (SPG11)</strong> is a form of <a href=\"https://rarediseases.info.nih.gov/GARD/Condition/6637/Hereditary_spastic_paraplegia.aspx\" target=\"_blank\">hereditary spastic paraplegia</a>. People with SPG11 experience worsening muscle stiffness leading to eventual paralysis of the lower limbs, as well as a range of other neurologic symptoms that may include intellectual disability, speech difficulties (dysarthria), and reduced bladder control.[2296] Additionally, the tissue connecting the left and right halves of the brain (corpus callosum) is abnormally thin in most individuals with SPG11. Onset of symptoms typically occurs during infancy or adolescence.[2298][11610] SPG11 is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in the <em><a href=\"http://www.ghr.nlm.nih.gov/gene=spg11\" target=\"_blank\">SPG11</a></em> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> fashion.[2297] Treatment is focused on managing symptoms and may include physical therapy and antispastic medications to prolong muscle control.[2298]<br />\r\n<br />","dateModified":"2016-05-31T00:00:00","references":[{"referenceId":2296,"authors":"","articleTitle":"Spastic paraplegia 11, autosomal recessive SPG11","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man","date":"2010","url":"http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=604360","dateAccessed":"2010-04-16T00:00:00"},{"referenceId":2297,"authors":"","articleTitle":"Spastic paraplegia type 11","bookWebsiteJournalTitle":"Genetics Home Reference","date":"2009","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/spastic-paraplegia-type-11","dateAccessed":"2016-05-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2298,"authors":"Stevanin G, Durr A, Brice A","articleTitle":"Spastic paraplegia 11","bookWebsiteJournalTitle":"GeneReviews","date":"January 31, 2013","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1210/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11610,"authors":"Martha A. Nance","articleTitle":"Hereditary Spastic Paraplegia","bookWebsiteJournalTitle":"NORD","date":"2013","volume":"","pages":"","url":"http://rarediseases.org/rare-diseases/hereditary-spastic-paraplegia/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":45,"questionText":"What is hereditary spastic paraplegia?","answerText":"<strong>Hereditary spastic paraplegia</strong>&nbsp;(HSP) is a group of hereditary, degenerative, neurological disorders that primarily affect the upper motor neurons.&nbsp;Upper motor neurons in the brain and spinal cord deliver signals to the lower motor neurons, which in turn, carry messages to the muscles.&nbsp;In hereditary spastic paraplegia, upper motor neurons slowly degenerate so the muscles do not receive the correct messages, causing progressive <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003297.htm\" target=\"_blank\">spasticity</a> (increased muscle tone/stiffness) and weakness of the legs. This leads to difficulty walking. As degeneration continues, symptoms worsen.[38] If only the lower body is affected, HSP is classified as uncomplicated or pure. HSP is classified as complicated or complex if other systems are involved. In these cases, additional symptoms, including impaired vision,&nbsp;<a href=\"http://www.ataxia.org/learn/ataxia-diagnosis.aspx\" target=\"_blank\">ataxia</a>, epilepsy, cognitive impairment,&nbsp;<a href=\"http://www.mayoclinic.org/diseases-conditions/peripheral-neuropathy/basics/definition/CON-20019948?p=1\" target=\"_blank\">peripheral neuropathy</a>, and/or deafness, occur.[38][4460] The different forms of HSP are caused by&nbsp;<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>&nbsp;in different&nbsp;<a href=\"http://www.genome.gov/glossary/index.cfm?id=70\" target=\"_blank\">genes</a>. Inheritance varies. There are no specific treatments to prevent, slow, or reverse HSP. Individual symptoms may be treated with medications and/or physical therapy.[4460][11330]&nbsp;","dateModified":"2016-04-24T00:00:00","references":[{"referenceId":38,"authors":"","articleTitle":"About HSP (Hereditary Spastic Paraplegia)","bookWebsiteJournalTitle":"Spastic Paraplegia Foundation, Inc.","date":"2019","volume":"","pages":"","url":"http://sp-foundation.org/understanding-pls-hsp/hsp.html","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":4460,"authors":"","articleTitle":"NINDS Hereditary Spastic Paraplegia Information Page","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke (NINDS)","date":"June 15, 2018","volume":"","pages":"","url":"https://www.ninds.nih.gov/disorders/all-disorders/hereditary-spastic-paraplegia-information-page","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11330,"authors":"Nance MA","articleTitle":"Hereditary Spastic Paraplegia","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2017","volume":"","pages":"","url":"http://rarediseases.org/rare-diseases/hereditary-spastic-paraplegia/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3332,"questionText":"What are the signs and symptoms of spastic paraplegia 11 (SPG11)?\r\n<p>&nbsp;</p>","answerText":"Signs and symptoms of SPG11 may include:[2297][2298]<br />\r\n<ul>\r\n    <li>&nbsp;<a href=\"http://www.ninds.nih.gov/disorders/spasticity/spasticity.htm\" target=\"_blank\">Spasticity</a> (progressive muscle stiffness)</li>\r\n    <li>&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/paralysis.html\" target=\"_blank\">Paraplegia</a>(eventual&nbsp;paralysis of the lower limbs) &nbsp;</li>\r\n    <li>&nbsp;Numbness, tingling, or pain in the arms and legs&nbsp;</li>\r\n    <li>&nbsp;Disturbance in the nerves used for muscle movement&nbsp;</li>\r\n    <li>&nbsp;<a href=\"http://www.parentcenterhub.org/repository/intellectual/#def\" target=\"_blank\">Intellectual disability</a></li>\r\n    <li>&nbsp;Exaggerated reflexes of the lower limbs&nbsp;</li>\r\n    <li>&nbsp;Speech difficulties (dysarthria)</li>\r\n    <li>&nbsp;Reduced bladder control&nbsp;</li>\r\n    <li>&nbsp;Muscle wasting&nbsp;</li>\r\n</ul>\r\n<p>Less common features, include:[2297]</p>\r\n<ul>\r\n    <li>Difficulty swallowing (dysphagia)</li>\r\n    <li>High-arched feet&nbsp;</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/scoliosis.html\" target=\"_blank\">Scoliosis</a>&nbsp;</li>\r\n    <li><a href=\"http://www.aoa.org/x9763.xml\" target=\"_blank\">Involuntary movements of the eyes</a></li>\r\n</ul>\r\n<p>Age&nbsp;at time of&nbsp;symptom onset&nbsp;varies from&nbsp;infancy&nbsp;to early adulthood, with onset in infancy to adolescence being most common. Learning disability may begin in childhood. Most people experience a decline in intellectual ability and an increase in muscle weakness and nerve abnormalities over time. As the condition progresses, some people require wheelchair assistance (often 10 to 20 years after&nbsp;symptom onset).[2297][2298]</p>","dateModified":"2016-05-31T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":2297,"authors":"","articleTitle":"Spastic paraplegia type 11","bookWebsiteJournalTitle":"Genetics Home Reference","date":"2009","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/spastic-paraplegia-type-11","dateAccessed":"2016-05-31T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2298,"authors":"Stevanin G, Durr A, Brice A","articleTitle":"Spastic paraplegia 11","bookWebsiteJournalTitle":"GeneReviews","date":"January 31, 2013","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1210/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":696,"questionText":"How can I learn more about research for hereditary spastic paraplegias?","answerText":"<p>The U.S. National Institutes of Health, through the National Library of Medicine, developed <a href=\"http://www.clinicaltrials.gov/\" target=\"_blank\">ClinicalTrials.gov</a> to provide patients, family members, and members of the public with current information on clinical research studies.&nbsp;You can find clinical trials&nbsp;for individuals with spastic paraplegias at the following link. After you click on a study, review its \"eligibility\" criteria to determine its appropriateness. Use the study&rsquo;s contact information to learn more. Check this site often for regular updates.&nbsp;<br />\r\n<a href=\"http://www.clinicaltrials.gov/ct2/results?term=spastic+paraplegias\" target=\"_blank\">http://www.clinicaltrials.gov/ct2/results?term=spastic+paraplegias</a></p>\r\n<p>You can also contact the Patient Recruitment and Public Liaison (PRPL) Office at the National Institutes of Health (NIH). We recommend calling the toll-free number listed below to speak with a specialist, who can help you find trials of interest.&nbsp;<br />\r\n<br />\r\nPatient Recruitment and Public Liaison Office<br />\r\nNIH Clinical Center<br />\r\nBethesda, Maryland 20892-2655<br />\r\nToll-free: 800-411-1222<br />\r\nFax: 301-480-9793<br />\r\nEmail: <a href=\"mailto:prpl@mail.cc.nih.gov\">prpl@mail.cc.nih.gov</a><br />\r\nWeb site:&nbsp; <a href=\"http://clinicalcenter.nih.gov/\" target=\"_blank\">http://clinicalcenter.nih.gov/</a></p>\r\n<p>If you are interested in enrolling in a clinical trial, you can find helpful general information on clinical trials at the <a href=\"http://clinicaltrials.gov/ct2/info/understand\" target=\"_blank\">ClinicalTrials.gov Web page</a>. Resources on many charitable or special-fare flights to research and treatment sites and low-cost hospitality accommodations for outpatients and family members, as well as ambulance services, are listed on the Web site of the <a href=\"http://rarediseases.info.nih.gov/Resources.aspx?PageID=8\" target=\"_blank\">Office of Rare Diseases Research (ORDR)</a>, part of the National Institutes of Health.<br />\r\n<br />\r\nYou can also learn more about current research&nbsp;from the Spastic Paraplegia Foundation.<br />\r\n<br />\r\nSpastic Paraplegia Foundation<br />\r\n1605 Goularte Place<br />\r\nFremont, CA&nbsp; 94539-7241<br />\r\nTel: 877-773-4483<br />\r\nFax: 877-773-4483<br />\r\nEmail: <a href=\"mailto:info@sp-foundation.org\">info@sp-foundation.org</a><br />\r\nWeb site: <a href=\"http://www.sp-foundation.org/\" target=\"_blank\">http://www.sp-foundation.org</a></p>","dateModified":"2013-10-18T11:37:00","references":[]},{"questionId":155,"questionText":"How can I find a genetics professional in my area?","answerText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the&nbsp;<a href=\"https://www.acmg.net/ACMG/Find_Genetic_Services/ACMG/ISGweb/FindaGeneticService.aspx?hkey=720856ab-a827-42fb-a788-b618b15079f9\" target=\"_blank\">American College of Medical Genetics</a>, and the&nbsp;<a href=\"https://www.findageneticcounselor.com/\" target=\"_blank\">National Society of Genetic Counselors</a>. If you need additional help,&nbsp;<a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href=\"http://ghr.nlm.nih.gov/handbook/consult?show=all\" target=\"_blank\">learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","dateModified":"2017-11-30T00:00:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13690,"phenoTypeName":"Aplasia/Hypoplasia of the corpus callosum","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13743,"phenoTypeName":"Cerebral cortical atrophy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8703,"phenoTypeName":"Dysarthria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9379,"phenoTypeName":"Gait disturbance","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8727,"phenoTypeName":"Mental deterioration","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10109,"phenoTypeName":"Nystagmus","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3053,"phenoTypeName":"Saccadic smooth pursuit","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8712,"phenoTypeName":"Spastic paraplegia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13742,"phenoTypeName":"Ventriculomegaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":10649,"phenoTypeName":"Hyperreflexia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2230,"phenoTypeName":"Peripheral neuropathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9404,"phenoTypeName":"Reduced tendon reflexes","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14305,"phenoTypeName":"Abnormality of the periventricular white matter","percentRanges":"-"},{"phenoTypeId":6254,"phenoTypeName":"Adult onset","percentRanges":"-"},{"phenoTypeId":8733,"phenoTypeName":"Agenesis of corpus callosum","percentRanges":"-"},{"phenoTypeId":4289,"phenoTypeName":"Ankle clonus","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":13598,"phenoTypeName":"Babinski sign","percentRanges":"-"},{"phenoTypeId":15655,"phenoTypeName":"Childhood onset","percentRanges":"-"},{"phenoTypeId":4021,"phenoTypeName":"Decreased number of peripheral myelinated nerve fibers","percentRanges":"-"},{"phenoTypeId":11408,"phenoTypeName":"Degeneration of the lateral corticospinal tracts","percentRanges":"-"},{"phenoTypeId":4498,"phenoTypeName":"Distal peripheral sensory neuropathy","percentRanges":"-"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","percentRanges":"-"},{"phenoTypeId":10110,"phenoTypeName":"Gaze-evoked nystagmus","percentRanges":"-"},{"phenoTypeId":13712,"phenoTypeName":"Hypoplasia of the corpus callosum","percentRanges":"-"},{"phenoTypeId":13841,"phenoTypeName":"Impaired vibration sensation in the lower limbs","percentRanges":"-"},{"phenoTypeId":4290,"phenoTypeName":"Knee clonus","percentRanges":"-"},{"phenoTypeId":13670,"phenoTypeName":"Lower limb muscle weakness","percentRanges":"-"},{"phenoTypeId":13449,"phenoTypeName":"Lower limb spasticity","percentRanges":"-"},{"phenoTypeId":9194,"phenoTypeName":"Macular degeneration","percentRanges":"-"},{"phenoTypeId":8509,"phenoTypeName":"Motor polyneuropathy","percentRanges":"-"},{"phenoTypeId":4079,"phenoTypeName":"Obesity","percentRanges":"-"},{"phenoTypeId":3896,"phenoTypeName":"Pes cavus","percentRanges":"-"},{"phenoTypeId":5255,"phenoTypeName":"Progressive","percentRanges":"-"},{"phenoTypeId":14147,"phenoTypeName":"Sensory neuropathy","percentRanges":"-"},{"phenoTypeId":13452,"phenoTypeName":"Spastic gait","percentRanges":"-"},{"phenoTypeId":9417,"phenoTypeName":"Specific learning disability","percentRanges":"-"},{"phenoTypeId":5587,"phenoTypeName":"Thenar muscle atrophy","percentRanges":"-"},{"phenoTypeId":1178,"phenoTypeName":"Tip-toe gait","percentRanges":"-"},{"phenoTypeId":7928,"phenoTypeName":"Urinary bladder sphincter dysfunction","percentRanges":"-"},{"phenoTypeId":6356,"phenoTypeName":"Urinary incontinence","percentRanges":"-"},{"phenoTypeId":6543,"phenoTypeName":"Urinary urgency","percentRanges":"-"},{"phenoTypeId":5614,"phenoTypeName":"Visual impairment","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Spastic_paraplegia_11"}